Additional file 2: Table S2. of Retention of normal glia function by an isoform-selective protein kinase inhibitor drug candidate that modulates cytokine production and cognitive outcomes

Zhengqiu Zhou (Contributor)
Adam D. Bachstetter (Creator)
Claudia B. Späni (Creator)
Saktimayee Mitra Roy (Contributor)
Daniel M Watterson (Contributor)
Linda J. van Eldik (Contributor)

Dataset

Description

IHC assays. Source data for GFAP data in Fig. 2 and CD68 and CD45 data in Fig. 4. (XLS 63 kb)

Date made available	2017
Publisher	figshare

DOI
10.6084/m9.figshare.c.3735430_d2.v1

Access Dataset

CC BY + CC0

1 Article

Retention of normal glia function by an isoform-selective protein kinase inhibitor drug candidate that modulates cytokine production and cognitive outcomes
Zhou, Z., Bachstetter, A. D., Späni, C. B., Roy, S. M., Watterson, D. M. & Van Eldik, L. J., Apr 5 2017, In: Journal of neuroinflammation. 14, 1, 75.
Research output: Contribution to journal › Article › peer-review

Open Access
20 Scopus citations

Cite this

Zhou, Z. (Contributor), Bachstetter, A. D. (Creator), Späni, C. B. (Creator), Roy, S. M. (Contributor), Watterson, D. M. (Contributor), Van Eldik, L. J. (Contributor) (2017). Additional file 2: Table S2. of Retention of normal glia function by an isoform-selective protein kinase inhibitor drug candidate that modulates cytokine production and cognitive outcomes. figshare. 10.6084/m9.figshare.c.3735430_d2.v1

Additional file 2: Table S2. of Retention of normal glia function by an isoform-selective protein kinase inhibitor drug candidate that modulates cytokine production and cognitive outcomes

Description

DOI

Access Dataset

Research output

Retention of normal glia function by an isoform-selective protein kinase inhibitor drug candidate that modulates cytokine production and cognitive outcomes

Cite this